Compare · SLDP vs TMO
SLDP vs TMO
Side-by-side comparison of Solid Power Inc. (SLDP) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- SLDP operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $198.47B, about 372.2x SLDP ($533.2M).
- Over the past year, SLDP is down 25.4% and TMO is up 27.9% - TMO leads by 53.4 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 5 for SLDP).
- TMO has more recent analyst coverage (25 ratings vs 11 for SLDP).
- Company
- Solid Power Inc.
- Thermo Fisher Scientific Inc
- Price
- $2.38+6.25%
- $534.57+1.11%
- Market cap
- $533.2M
- $198.47B
- 1M return
- -15.63%
- +12.38%
- 1Y return
- -25.43%
- +27.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 5
- 9
- Recent ratings
- 11
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SLDP
- SEC Form 3 filed by new insider Breitweg Uwe Michael
- Solid Power Appoints Uwe Breitweg to Board of Directors, Adding Deep Automotive and Battery Strategy Expertise
- President & CEO Van Scoter John C. covered exercise/tax liability with 154,512 shares, decreasing direct ownership by 3% to 4,717,639 units (SEC Form 4)
- CFO, Treasurer, & Secretary Heller Linda C. covered exercise/tax liability with 72,310 shares, decreasing direct ownership by 4% to 1,948,844 units (SEC Form 4)
- Chief Technology Officer Buettner-Garrett Joshua covered exercise/tax liability with 33,824 shares, decreasing direct ownership by 2% to 1,366,018 units (SEC Form 4)
- Solid Power Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Alliance Global Partners initiated coverage on Solid Power with a new price target
- Amendment: Director Goldberg Steven H was granted 44,133 shares, increasing direct ownership by 37% to 162,941 units (SEC Form 4)
- Director Wright Maryann was granted 44,133 shares, increasing direct ownership by 15% to 331,730 units (SEC Form 4)
- Director Stephens John Joseph was granted 44,133 shares, increasing direct ownership by 16% to 320,203 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target